Newsletter | July 9, 2024

07.09.24 -- $25 Million Awards Help Cancer Researchers Make Clinical Trial Inroads

FEATURED EDITORIAL

$25 Million Awards Help Cancer Researchers Make Clinical Trial Inroads

Cancer Grand Challenges — a global research initiative cofounded by Cancer Research U.K. and the National Cancer Institute in the U.S. — supports cancer research that aims to answer some of the field’s most dire questions and pertinent needs.

INDUSTRY INSIGHTS

Diagnose Absorption Risks To Improve Preclinical And Clinical Outcomes

Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

Components Of An Effective Disinfectant Prequalification Strategy

Cleaning procedures designed specifically to destroy microbial contaminants that may be present are an important component of any microbial control strategy.

Increasing Bioavailability With Amorphous Solid Dosage Formulations

Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

Optimizing Kinetics Assays To Avoid Avidity Effects

Considering affinity and avidity early in assay design can ensure the desired assay parameters are achieved. Learn about affinity and avidity and how to recognize and resolve issues that may arise.

An Introduction To Gene Therapy And Its Drug Development Applications

Gain an understanding of gene therapy, including its history, advantages, disadvantages, and in vivo and ex vivo processes, as well as how Organ-Chips can be utilized to advance gene therapy development.

MOST POPULAR NEWS

Scientists Use Computational Modeling To Guide A Difficult Chemical Synthesis

Vertex Announces FDA Acceptance Of NDA For Vanzacaftor/Tezacaftor/Deutivacaftor

Inozyme Pharma Announces FDA Fast Track Designation For INZ-701 In ABCC6 Deficiency

SCG Cell Therapy Announces FDA IND Clearance Of SCG142

Owkin, An AI-Biotech Unicorn, Expands Into DACH Region To Accelerate Research

Eisai Moves To Solo Development And Commercialization Of FZEC ADC

McGill, Industry, CQDM And Brain Canada Collaborate For Drug Discovery

Soleno Therapeutics Submits NDA To FDA For DCCR Extended-Release Tablets

Genexine Announces Merger With EPD Biotherapeutics

Anacura Acquires OHMX.bio, Adding Multi-Omics To Its Services

Hyundai Bioscience Succeeds In Developing Dengue Fever Multi-Treatment Drug

SOLUTIONS

Biopharmaceutical Services

Bionanoparticle Technology

Efficient Viral Vector Production: A Rentschler Collaboration Story